Search Results - "Essler, M."

PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival by Rahbar, K., Boegemann, M., Yordanova, A., Eveslage, M., Schäfers, M., Essler, M., Ahmadzadehfar, H.

“…Aim Our aim was to evaluate overall survival and parameters prognosticating longer survival in a large and homogeneous group of patients treated with 177…”
Get full text

DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial by Krausewitz, P, Bundschuh, R A, Gaertner, F C, Essler, M, Attenberger, U, Luetkens, J, Kristiansen, G, Muders, M, Ohlmann, C-H, Hauser, S, Ellinger, J, Ritter, M

“…The primary objective is to determine the proportion of men with suspected prostate cancer (PCA) in whom the management plans are changed by additive…”
Get full text

Measuring and modeling patient-specific distributions of material properties in abdominal aortic aneurysm wall by Reeps, C., Maier, A., Pelisek, J., Härtl, F., Grabher-Meier, V., Wall, W. A., Essler, M., Eckstein, H.-H., Gee, M. W.

“…Both the clinically established diameter criterion and novel approaches of computational finite element (FE) analyses for rupture risk stratification of…”
Get full text

Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga–PSMA uptake in LNCaP cells by Mathy, C. S., Mayr, T., Kürpig, S., Meisenheimer, M., Dolscheid-Pommerich, R. C., Stoffel-Wagner, B., Kristiansen, G., Essler, M., Muders, M. H., Bundschuh, R. A.

“…Background In recent years, a variety of innovative therapeutics for castration-resistant prostate cancer have been developed, including novel anti-androgenic…”
Get full text

Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours by Gaertner, F.C., Plum, T., Kreppel, B., Eppard, E., Meisenheimer, M., Strunk, H., Bundschuh, R.A., Sinnes, J.P., Rösch, F., Essler, M.

“…[68Ga]Ga-DATA-TOC is a new radiolabelled somatostatin-analogue for positron emission tomography (PET) imaging of neuroendocrine tumours. Its advantage over…”
Get full text

Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy by Essler, M., Wantke, J., Mayer, B., Scheidhauer, K., Bundschuh, R.A., Haller, B., Astner, S.T., Molls, M., Andratschke, N.

“…Purpose To evaluate the diagnostic value of positron-emission tomography/computed tomography (PET/CT) in stage I lung cancer patients treated with stereotactic…”
Get full text

A Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours by Yordanova, A, Ahmadzadehfar, H, Gonzalez-Carmona, M, Strassburg, C, Mayer, K, Feldmann, G, Schmidt-Wolf, I, Lingohr, P, Fischer, S, Kristiansen, G, Essler, M

“…Neuroendocrine tumours (NET) are rare neoplasms, but the incidence is permanently increasing. Most of the NETs are slow proliferating and clinically silent,…”
Get more information

Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases by Bundschuh, R.A., Andratschke, N., Dinges, J., Duma, M.N., Astner, S.T., Brügel, M., Ziegler, S.I., Molls, M., Schwaiger, M., Essler, M.

“…Purpose The use of 4D-[ 18 F]fluorodeoxyglucose (FDG) PET/CT in combination with respiratory gated magnet resonance imaging (MRI) in target volume definition…”
Get full text

Postacquisition Detection of Tumor Motion in the Lung and Upper Abdomen Using List-Mode PET Data: A Feasibility Study by Bundschuh, Ralph A, Martinez-Moeller, Axel, Essler, Markus, Martinez, Maria-Jose, Nekolla, Stephan G, Ziegler, Sibylle I, Schwaiger, Markus

“…One of the main degrading factors in the quality of oncologic PET images of the thorax and upper abdomen is respiratory motion of tumors. One method to reduce…”
Get full text

PD-0279 VALUE OF 18F-FDG-PET/CT AFTER STEREOTACTIC BODY RADIATION THERAPY FOR STAGE I NON-SMALL CELL LUNG CANCER by Andratschke, N, Wantke, J, Mayer, B, Bundschuh, R.A, Haller, B, Astner, S.T, Molls, M, Essler, M

Get full text

Renal accumulation of [111In]DOTATOC in rats: influence of inhibitors of the organic ion transport and diuretics by Stahl, A R, Wagner, B, Poethko, T, Perutka, M, Wester, H J, Essler, M, Heemann, U, Schwaiger, M, Lutz, J

“…Radiation exposure to the kidney limits therapy with radiometal labelled DOTATOC. This study evaluates the organic anion and cation transport (inhibitors:…”
Get full text

18F-Octreotate Positron Emission Tomography (PET) for Target Volume Delineation in Stereotactic Radiation Therapy Planning of Glomus Tumors by Astner, S.T, Essler, M, Bundschuh, R.A, Beer, A, Grosu, A

Get full text

Odyssey Towards a Sirenic Thinking: An Attempt at a Self-Criticism of the Listening Paradigm Within Sound Studies by Kallenberg, Jim Igor, Eßler, Hannah L. M.

“…Abstract This text departs from a contradictory claim in deaf studies and sound studies: both disciplines describe a hierarchical regime of the sensible –…”
Get full text

68Ga-DOTATOC-PET/CT detects neuroendocrine differentiation of prostate cancer metastases by Souvatzoglou, M, Maurer, T, Treiber, U, Weirich, G, Krause, B J, Essler, M

Get more information

Karzinoide der Lunge by Stoelben, E., Yordanova, A., Gossmann, A., Hammer-Hellmig, M., Brossart, P., Mayer, K., Essler, M.

“…Im Idealfall ist eine parenchymschonende radikale Resektion möglich, und die Heilungschancen sind gut. Im Gegensatz zu dem geringen Effekt einer klassischen…”
Get full text

P337 - DEPROMP-Study: PSMA-PET/CT prior to prostate biopsy: Enhancing prostate cancer detection and personalized management by Krausewitz, P., Gaertner, F.C., Essler, M., Attenberger, U., Luetkens, J., Kristiansen, G., Ohlmann, C.H., Hauser, S., Ellinger, J., Ritter, M.

Get full text

DEPROMP-Study: PSMA-PET/CT prior to prostate biopsy: Enhancing prostate cancer detection and personalized management by Krausewitz, P., Gaertner, F.C., Essler, M., Attenberger, U., Luetkens, J., Kristiansen, G., Ohlmann, C.H., Hauser, S., Ellinger, J., Ritter, M.

Get full text

2027 4D FDG-PET/CT combined with diffusion weighted MRI for planning of stereotactic radiation therapy of liver metastasis by Andratschke, N, Bundschuh, R.A, Bruegel, M, Essler, M, Molls, M, Astner, S.T

Get full text

DEPROMP Trial: The additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men by Krausewitz, P., Gärtner, F.C., Essler, M., Attenberger, U., Luetkens, J., Kristiansen, G., Ohlmann, C.H., Hauser, S., Ellinger, J., Ritter, M.

Get full text

A0056 - DEPROMP Trial: The additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men by Krausewitz, P., Gärtner, F.C., Essler, M., Attenberger, U., Luetkens, J., Kristiansen, G., Ohlmann, C.H., Hauser, S., Ellinger, J., Ritter, M.

Get full text